Sonic Healthcare (SHL) News

ASXPrice sensitive

Neutral

30 Sept

director_dealing announcement

ASXPrice sensitive

Neutral

30 Sept

director_dealing announcement

Kalkine

Neutral

25 Sept

Highlights Pathology giant's shares have fallen hard over the past month Research houses kept neutral stances this week Medical AI investment hints at a longer-term play Sonic Healthcare (ASX:SHL) is trying to find a floor this week after a sharp slide over the past month, with a pair of major research houses keeping neutral stances on the pathology and radiology group even as its dividend yield has climbed well above the market average. A Month to Forget Sonic's share price has fallen steepl...

ASXPrice sensitive

Neutral

24 Sept

other announcement

Kalkine

Neutral

24 Sept

Highlights Sonic Healthcare is trading closer to its yearly low than its high, after its shares went ex-dividend earlier this month. Its forward dividend yield has attracted attention as bank deposit rates remain below earlier levels. Earnings have been normalising after the pandemic testing boom, with profit rising again in the latest year. Sonic Healthcare (ASX:SHL) is in focus today as healthcare stocks continue to provide support for the Australian market, with the global pathology and im...

ASXPrice sensitive

Neutral

23 Sept

other announcement

ASXPrice sensitive

Neutral

23 Sept

other announcement

ASXPrice sensitive

Neutral

23 Sept

other announcement

ASXPrice sensitive

Neutral

23 Sept

other announcement

ASXPrice sensitive

Neutral

23 Sept

other announcement

ASXPrice sensitive

Neutral

23 Sept

other announcement

Kalkine

Neutral

22 Sept

Highlights Sonic Healthcare Limited (ASX:SHL) operates pathology and diagnostic imaging services across several countries. Its scale in laboratory medicine places it firmly within the Healthcare Stocks category. Patient testing volumes and healthcare system demand remain central to its performance. Diagnostic testing forms a quiet but essential backbone of modern healthcare, and Sonic Healthcare Limited (ASX:SHL) remains one of the largest names providing that service across multiple countrie...

Motley Fool

Neutral

21 Sept

This could be a very healthy opportunity to buy. The post Down more than 18% in a month with a 7% yield, are Sonic Healthcare shares too cheap to ignore? appeared first on The Motley Fool Australia.

Kalkine

Neutral

17 Sept

Highlights Sonic Healthcare Limited (ASX:SHL) operates pathology and diagnostic imaging services across several countries. Its scale in laboratory medicine places it firmly within the Healthcare Stocks category. Patient testing volumes and healthcare system demand remain central to its performance. Diagnostic testing forms a quiet but essential backbone of modern healthcare, and Sonic Healthcare Limited (ASX:SHL) remains one of the largest names providing that service across multiple countrie...

Kalkine

Neutral

14 Sept

Highlights The pathology group lifted annual revenue and underlying profit following a run of substantial offshore acquisitions. [ASX 100] A major German diagnostics purchase moved the business into a leading position in Europe's second-largest market. A review of United States operations is underway, targeting rationalisation and withdrawal from loss-making activities. Sonic Healthcare (ASX:SHL) lifted annual revenue and underlying profit as a run of offshore acquisitions bedded down, with a...

Kalkine

Neutral

11 Sept

Highlights The pathology group has been trading near its weakest level in about a decade. Margin recovery in laboratory medicine is the central question for the year ahead. Recent European and American acquisitions are still being integrated for synergies. Sonic Healthcare (ASX:SHL) spent the week close to its weakest level in about a decade, caught between a sector-wide repricing and a margin recovery that the market has been waiting on for longer than it expected. The pathology group has fa...

Google News

Neutral

4 Sept

Sonic Healthcare (ASX:SHL) Nudges Higher — Should This Pathology Stock Be on Your Watchlist?  Kalkine

ASXPrice sensitive

Neutral

3 Sept

other announcement

Kalkine

Neutral

3 Sept

Highlights Full-year profit climbed markedly as management leaned further into digital pathology investment. Bolt-on acquisitions across core laboratory markets stayed on track alongside the earnings improvement. The stock's dividend yield drew renewed attention as shares extended a strong post-results rally. Sonic Healthcare Limited (ASX:SHL), the global pathology and diagnostic imaging group, reported a jump in full-year profit alongside a stepped-up digital investment programme, a strong s...

ASXPrice sensitive

Neutral

2 Sept

other announcement

ASXPrice sensitive

Neutral

2 Sept

other announcement

ASXPrice sensitive

Neutral

2 Sept

other announcement

ASXPrice sensitive

Neutral

2 Sept

other announcement

Kalkine

Neutral

31 Aug

Highlights Sonic Healthcares defensive diagnostics profile places essential healthcare demand at the centre of the retirement-income discussion. The companys global laboratory network supports a broad operating base across several developed healthcare markets. Dividend history, payout discipline and long-term health-service demand remain the key themes behind the FY27 income narrative. Australian healthcare names often attract attention when market conditions become more selective, and Sonic...

Google News

Neutral

28 Aug

Why Sonic Healthcare (ASX:SHL) Is Back In The Spotlight  simplywall.st

ASX

Neutral

26 Aug

other announcement

ASX

Neutral

20 Aug

other announcement

Google News

Neutral

20 Aug

Why Sonic Healthcare (ASX:SHL) Is Up 5.7% After Stronger FY26 Revenue And Earnings Results  simplywall.st

Kalkine

Neutral

20 Aug

Highlights The coverage gives Sonic its own evidence hierarchy: first cost discipline, then medium-term visibility, and finally demand sensitivity, with All Ordinaries used only as an external frame. Sonic is approached from the quality of demand sensitivity, not from a broad market-direction call. The analysis works backwards from cost discipline to test what medium-term visibility is actually saying about the business. That company-first framing keeps the All Ordinaries reference useful witho...

ASX

Neutral

19 Aug

other announcement

ASX

Neutral

19 Aug

other announcement

ASX

Neutral

19 Aug

other announcement

Kalkine

Neutral

18 Aug

Highlights Routine testing economics after laboratory normalisation is the central company-specific issue, with test volumes providing the first operating check. Lab productivity and acquisition integration show whether activity is translating into commercial quality and financial discipline. Wage pressure and uneven reimbursement remains the main constraint that could interrupt the operating sequence. The Australian market is in a phase where company-specific proof matters more than a broad ...

Kalkine

Neutral

18 Aug

Highlights Sonic Healthcare has taken a meaningful stake in a precision microbiome diagnostics company as part of a broader growth push. The pathology and imaging group has also been expanding its German laboratory network through a recent acquisition. Organic revenue growth and a reaffirmed earnings outlook have positioned Sonic as a relatively steady name this reporting season. Sonic Healthcare (ASX:SHL) has continued to broaden its diagnostics footprint, taking a stake in specialist microb...

ASX

Neutral

17 Aug

other announcement

Kalkine

Neutral

17 Aug

Highlights Sonic Healthcare is viewed through clinical demand, product adoption and service volumes, keeping the discussion anchored to company-specific operating evidence. The Healthcare Stocks lens is used only as context; the article separates Sonic Healthcare's business model from broader sector shorthand. Fresh disclosures around regulatory pathway, capacity utilisation and international reach are the most useful checkpoints for judging how the narrative is evolving. Company-specific evi...

Kalkine

Neutral

17 Aug

Highlights Pathology volume recovery has restored the cash base behind a long running healthcare distribution. Offshore laboratory earnings dilute franking but broaden the currency mix supporting the payout. Acquisition led expansion is competing with cash returns for the same balance sheet capacity. Sonic Healthcare (ASX:SHL), one of the largest laboratory medicine and diagnostic imaging groups listed on the Australian market, has drawn a firmer income narrative this week as reporting season...

Kalkine

Neutral

16 Aug

Highlights Sonic Healthcare enters the next results phase with stronger revenue momentum, resilient diagnostics demand and a broader international platform. The valuation debate centres on whether earnings growth, margins and cash conversion can support renewed market confidence after a softer share-price period. Recent portfolio and property transactions add balance-sheet flexibility, while acquisition integration and operating discipline remain key tests. Sonic Healthcare is returning to ma...

Kalkine

Neutral

15 Aug

Highlights Sonic Healthcare remains in focus as pathology demand, acquisition integration and earnings quality shape its valuation narrative. Recent operating progress points to improving scale benefits, while capital discipline remains important after a period of portfolio expansion. The next full-year update should clarify margins, cash conversion and whether recent growth can translate into stronger returns on invested capital. Sonic Healthcare (ASX:SHL) is back in focus as Australian heal...

Kalkine

Neutral

15 Aug

Highlights Sonic Healthcare continues to expand its global healthcare footprint despite softer earnings trends. Revenue has remained resilient, while valuation metrics suggest the shares are trading below historical levels. Profitability, debt levels and return on equity remain key indicators to watch before assessing long-term value. Australia's share market continues to present investors with opportunities across defensive sectors, particularly healthcare, where established businesses ...

Kalkine

Neutral

13 Aug

Highlights Pathology and diagnostic imaging services supporting healthcare infrastructure Laboratory services network expansion serving regional markets Healthcare provider consolidation supporting service integration Sonic Healthcare (ASX:SHL) provides diagnostic services supporting healthcare infrastructure. The company continues expanding pathology and imaging networks serving Australia's regional healthcare requirements. The broader market context can also be viewed through the S&P/...

Kalkine

Neutral

12 Aug

Highlights Sonic Healthcare and Ramsay Health Care are being assessed through operational delivery, strategic priorities and the quality of their underlying platforms. Fisher & Paykel Healthcare and Sigma Healthcare highlight how sector conditions can create different requirements across established and emerging business models. Capital discipline, customer relevance and consistent execution remain central as the four companies progress their current work programs. Australias market conve...

Kalkine

Neutral

11 Aug

Highlights Sonic Healthcare is approaching its full-year result after a challenging period for large Australian healthcare names. Pathology scale, European acquisitions, UK outsourcing activity and improvements in the US business could shape the next phase. The upcoming update may provide clearer evidence on margins, operational efficiency and how the group is managing pressure across global diagnostics markets. Sonic Healthcare is heading into its latest full-year update with the market watch...

Kalkine

Neutral

11 Aug

Highlights Sonic Healthcare remains in focus as investors assess diagnostic volumes and margin recovery through reimbursement quality, a key indicator of whether current momentum can translate into durable operating progress. August reporting season is sharpening attention on commercial adoption and research discipline, helping investors distinguish headline activity from the underlying quality of the business outlook. A key risk is that regulatory pathways can stretch launch timing, which coul...

Kalkine

Neutral

4 Aug

Highlights Sonic Healthcare is drawing attention today around diagnostics activity. The update gives the sector a fresh company-specific news hook. Execution and wider market conditions remain central to the next read-through. Sonic Healthcare (ASX:SHL) is in focus today as the Australian market weighs diagnostics activity, putting the companys latest operational narrative at the centre of a busy local trading session. Why the update matters now The immediate reaction matters less than the re...

Kalkine

Neutral

3 Aug

Highlights Sonic Healthcare enters the reporting period with test volumes and labour costs central to the next company disclosure and the wider market debate. The Healthcare Stocks backdrop is testing volumes, reimbursement and operating margins as rates, demand and capital discipline shape market interpretation. A comparison with Healius clarifies differences in scale, operating exposure, funding needs and sensitivity to external conditions. Australia's listed market approaches the current re...

Google News

Neutral

23 July

Sonic Healthcare (ASX:SHL): What Does the Recent Share Price Performance Suggest?  Kalkine